KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $119.1 million.

  • Bio-Rad Laboratories' Free Cash Flow rose 4649.45% to $119.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $374.6 million, marking a year-over-year increase of 2935.08%. This contributed to the annual value of $374.6 million for FY2025, which is 2935.08% up from last year.
  • Bio-Rad Laboratories' Free Cash Flow amounted to $119.1 million in Q4 2025, which was up 4649.45% from $89.2 million recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Free Cash Flow registered a high of $195.7 million during Q3 2021, and its lowest value of -$16.6 million during Q3 2022.
  • In the last 5 years, Bio-Rad Laboratories' Free Cash Flow had a median value of $67.1 million in 2023 and averaged $75.0 million.
  • In the last 5 years, Bio-Rad Laboratories' Free Cash Flow plummeted by 10846.8% in 2022 and then skyrocketed by 42355.35% in 2023.
  • Bio-Rad Laboratories' Free Cash Flow (Quarter) stood at $114.7 million in 2021, then plummeted by 60.96% to $44.8 million in 2022, then dropped by 13.51% to $38.7 million in 2023, then skyrocketed by 109.89% to $81.3 million in 2024, then surged by 46.49% to $119.1 million in 2025.
  • Its Free Cash Flow was $119.1 million in Q4 2025, compared to $89.2 million in Q3 2025 and $70.8 million in Q2 2025.